Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911512 | 12591151 | 2 | F | 201603 | 20160328 | 20160726 | 20160727 | PER | US-UNITED THERAPEUTICS-UNT-2016-004154 | UNITED THERAPEUTICS | 69.50 | YR | F | Y | 84.85000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125911512 | 12591151 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.019 ?G/KG, CONTINUING | 926116 | 21272 | .019 | UG/KG | INJECTION | ||||||
| 125911512 | 12591151 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.020 ?G/KG, CONTINUING | 926116 | 21272 | .02 | UG/KG | INJECTION | ||||||
| 125911512 | 12591151 | 3 | C | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 125911512 | 12591151 | 4 | C | ADCIRCA | TADALAFIL | 1 | Unknown | 0 | |||||||||||
| 125911512 | 12591151 | 5 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125911512 | 12591151 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125911512 | 12591151 | 7 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | 0 | ||||||||||||
| 125911512 | 12591151 | 8 | C | METOPROLOL /00376902/ | METOPROLOL | 1 | 0 | ||||||||||||
| 125911512 | 12591151 | 9 | C | INSULIN /00646001/ | INSULIN NOS | 1 | 0 | ||||||||||||
| 125911512 | 12591151 | 10 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125911512 | 12591151 | 1 | Pulmonary arterial hypertension |
| 125911512 | 12591151 | 3 | Product used for unknown indication |
| 125911512 | 12591151 | 4 | Product used for unknown indication |
| 125911512 | 12591151 | 5 | Product used for unknown indication |
| 125911512 | 12591151 | 6 | Product used for unknown indication |
| 125911512 | 12591151 | 7 | Product used for unknown indication |
| 125911512 | 12591151 | 8 | Product used for unknown indication |
| 125911512 | 12591151 | 9 | Product used for unknown indication |
| 125911512 | 12591151 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125911512 | 12591151 | Faeces soft | |
| 125911512 | 12591151 | Myalgia | |
| 125911512 | 12591151 | Pain | |
| 125911512 | 12591151 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125911512 | 12591151 | 1 | 20160303 | 0 |